Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR.
Jaegyun Lim, Seunghyun Jeon, Hyun Young Shin, Moon Jung Kim, Yu Min Seong, Wang Jun Lee, Kang Won Choe, Yu Min Kang, Baeckseung Lee, Sang Joon Park
February 2020Synopsis of Social media discussions
The overall tone reflects cautious support and curiosity, with discussions referencing the study's details such as the effectiveness of lopinavir/ritonavir in reducing viral loads and the significance of tertiary transmission cases, emphasizing its relevance during the early stages of the pandemic. Words like 'potential,' 'significant decrease,' and 'important case' underscore a moderate agreement and a serious interest in clinical insights.
Agreement
Moderate agreementMost discussions acknowledge the potential effectiveness of lopinavir/ritonavir in treating COVID-19 pneumonia, showing moderate agreement with the study's findings.
Interest
Moderate level of interestParticipants display a cautious but genuine interest, mainly focusing on the clinical implications and relevance of the research.
Engagement
Moderate level of engagementThe posts demonstrate active engagement by referencing specific details from the publication and considering its significance within the COVID-19 treatment landscape.
Impact
Moderate level of impactThe conversations suggest a meaningful impact with some users highlighting the importance of this case study in understanding transmission and treatment efficacy.
Social Mentions
YouTube
3 Videos
17 Posts
News
11 Articles
Metrics
Video Views
5,369
Total Likes
70
Extended Reach
39,103
Social Features
31
Timeline: Posts about article
Top Social Media Posts
青島周一
カレトラかぁ。
Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment... - PubMed - NCBI https://t.co/unoQ45ECjP
view full post
へへへのヘビーメタロウ
新型コロナ（COVID 19）に関して、
カレトラを使用した症例報告は論文として出たみたいやね。韓国の事例。
https://t.co/DelzbgYsvP
view full post
@COVID_Evidence
Core Pubmed: Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative… https://t.co/PiYqsa24Qh #coronavirus #SARS_CoV_2 #covid19
view full post
Irena Yu
Letter to the Editor: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR - JKMS
https://t.co/YomiKSmgJh
view full post
PubMed Trending
Trending on PubMed: Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR. https://t.co/x5OSRW2EdG
view full post
Posts referencing the article
Impacts of Climate Change on Marine Biodiversity
This video explores the impacts of climate change on marine biodiversity. It discusses key findings on species adaptation, habitat loss, and conservation strategies in the face of rising temperatures and ocean acidification, providing insights into the vital balance of marine ecosystems.
February 23, 2020
2,564 views
COVID-19 Transmission Case and Lopinavir/Ritonavir Treatment Effectiveness
This case involves a 54-year-old South Korean male, the third confirmed COVID-19 patient, causing secondary and tertiary transmissions, highlighting rapid spread. Treatment with lopinavir-ritonavir showed a significant decrease in viral loads.
February 25, 2020
1,904 views
Analysis of COVID-19 Transmission and Treatment with Lopinavir-Ritonavir in Korea
This video examines a 54-year-old male COVID-19 case in South Korea, highlighting rapid virus spread and the potential effectiveness of lopinavir-ritonavir therapy in reducing viral loads and managing pneumonia.
February 21, 2020
902 views
-
Letter to the Editor: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR - JKMS https://t.co/YomiKSmgJh
view full postMarch 22, 2020
1
-
@COVID_Evidence
@COVID_Evidence (Twitter)Core Pubmed: Letter to the Editor: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia… https://t.co/IBLxrIlYi7 #coronavirus #SARS_CoV_2 #covid19
view full postMarch 18, 2020
-
@COVID_Evidence
@COVID_Evidence (Twitter)Core Pubmed: Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative… https://t.co/PiYqsa24Qh #coronavirus #SARS_CoV_2 #covid19
view full postMarch 17, 2020
1
-
Carlos E. Guzman
@arritmiasmx (Twitter)https://t.co/AyfK03EnQz https://t.co/L9kUVV7lFU
view full postMarch 17, 2020
-
へへへのヘビーメタロウ
@Metallaw666 (Twitter)新型コロナ（COVID 19）に関して、 カレトラを使用した症例報告は論文として出たみたいやね。韓国の事例。 https://t.co/DelzbgYsvP
view full postMarch 1, 2020
2
-
織田真理
@kuins (Twitter)RT @syuichiao89: カレトラかぁ。 Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lop…
view full postMarch 1, 2020
2
-
織田真理
@kuins (Twitter)RT @MissSimone: Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Rit…
view full postMarch 1, 2020
1
-
織田真理
@kuins (Twitter)RT @PaperbirdsH: New article: Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of…
view full postMarch 1, 2020
1
-
Santiago
@umsadiza (Twitter)@TomasCaroPaton @el_pais https://t.co/IOZYvmauIJ
view full postFebruary 29, 2020
-
NFTdose
@PaperbirdsH (Twitter)New article: The Author's Response: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by… https://t.co/SFcUYQ8Xei #coronavirus #wuhan #2019ncov
view full postFebruary 22, 2020
-
NFTdose
@PaperbirdsH (Twitter)New article: Letter to the Editor: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by… https://t.co/Tvwz1v1SMU #coronavirus #wuhan #2019ncov
view full postFebruary 22, 2020
-
Lost In Transit...
@themistella (Twitter)Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR https://t.co/bikPtp8DQh
view full postFebruary 22, 2020
-
김정한 Jeong Han Kim
@DrJHK (Twitter)RT @DrJHK: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ri…
view full postFebruary 17, 2020
1
-
青島周一
@syuichiao89 (Twitter)カレトラかぁ。 Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment... - PubMed - NCBI https://t.co/unoQ45ECjP
view full postFebruary 17, 2020
2
2
-
PubMed Trending
@PubTrend (Twitter)Trending on PubMed: Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR. https://t.co/x5OSRW2EdG
view full postFebruary 16, 2020
-
Simone Bosco
@MissSimone (Twitter)Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment o... - PubMed - NCBI https://t.co/1fwO9dsw30
view full postFebruary 15, 2020
1
-
NFTdose
@PaperbirdsH (Twitter)New article: Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR. https://t.co/uLTVztMf65 #coronavirus #wuhan #2019ncov
view full postFebruary 15, 2020
1
Abstract Synopsis
- The case involves a 54-year-old male in South Korea who was the third confirmed COVID-19 patient and caused secondary and tertiary transmissions, highlighting the virus's rapid spread.
- The patient experienced mild respiratory symptoms initially, with pneumonia developing by day 6 of hospitalization, and his clinical course included transmission to others outside China.
- The study reports that treatment with lopinavir-ritonavir (Kaletra) was associated with a significant decrease in viral loads, suggesting it may be effective in managing COVID-19 pneumonia.]
Irena Yu
@irinamow (Twitter)